During the last century, there has been an increasing prevalence of hyperuricaemia noted in
many populations. While uric acid is usually discussed in the context of gout …

Uric acid is the final product of purine metabolism, and its increased serum levels have been
directly involved in the pathogenesis and natural history of hypertension. The relationship …

Uric acid, once viewed as an inert metabolic end-product of purine metabolism, has been
recently incriminated in a number of chronic disease states, including hypertension …

Prehypertension frequently progresses to hypertension, a condition associated with high
morbidity and mortality from cardiovascular diseases and stroke. However, the risk factors …

Sodium/glucose co‐transporter‐2 (SGLT2) inhibitors, which lower blood glucose by
increasing renal glucose elimination, have been shown to reduce the risk of adverse …

Purine metabolism in the circulatory system yields uric acid as its final oxidation product,
which is believed to be linked to the development of gout and kidney stones. Hyperuricemia …

Abstract The latest European Guidelines of Arterial Hypertension have officially introduced
uric acid evaluation among the cardiovascular risk factors that should be evaluated in order …

The definition of hyperuricemia (HU) varies widely in different studies, which makes the
epidemiological reports somewhat inconsistent. HU remains the culprit of the pathogenesis …

Hyperuricemia has long been recognized to be associated with increased cardiovascular
risk, including risk of developing hypertension. Epidemiological findings suggest that the link …

Uric acid (UA) is the final product of the catabolism of endogenous and exogenous purine
nucleotides. While its association with articular gout and kidney disease has been known for …